MedTrace Logo

Paraesternal Blockade and Lactate Serum Levels in Patients with Cardiac Surgery.

NCT06608290 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2024-09-24

No results posted yet for this study

Summary

Parasternal blockade has been related to a reduction of the postoperative inflammatory response, by inhibition of the stress response, leading to a better prognosis. Increased lactate level is a useful parameter in identifying patients at risk of postoperative morbidity and mortality. The objective was to evaluate the association between parasternal blockade and serum lactate level in patients undergoing cardiac surgery, both trans- and post-anesthesia. 86 patients between 60-70 years of age participated. An association was found between the application of parasternal blockade in cardiac surgery and the presence of lower trans and postanesthetic serum lactate levels.

Conditions

  • Parasternal Block
  • Cardiac Surgery
  • Serum Lactate

Interventions

PROCEDURE

parasternal block

Administration of parasternal block with ropivacaine, bilaterally at the sternum before the start of surgery.

DIAGNOSTIC_TEST

Lactate serum level

Blood samples were taken to identify serum lactate levels greater than 2 mmol/l and those that remained below this limit.

Sponsors & Collaborators

  • Instituto Mexicano del Seguro Social

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2024-09-02

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06608290 on ClinicalTrials.gov